Spoken Alpha
Adagio Medical Holdings, Inc.
Adagio Medical designs and develops catheter-based cryoablation systems for treating cardiac arrhythmias, specifically ventricular tachycardia in patients with structural heart disease. The company's proprietary Ultra-Low Temperature Ablation (ULTA) technology creates deep, durable lesions in heart tissue to eliminate abnormal electrical pathways.
Adagio Medical Holdings, Inc is a Healthcare company operating in Medical Devices with a $11.6M market cap.
ADGM beat consensus EPS by 0.2% in Q2 FY2026, reported Aug 10, 2026.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-08-30.
Transcripts
We index calls for roughly 3,000 US-listed companies. If you'd like us to add ADGM, reply to your welcome email and we'll prioritize it.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for ADGM.
$ curl https://api.spokenalpha.com/v1/companies/ADGMFAQ
Spoken Alpha indexes ADGM's earnings call transcripts at https://spokenalpha.com/companies/ADGM. Each call links to attributed speakers and parsed analyst Q&A. Adagio Medical Holdings, Inc.'s own investor relations page is at https://investors.adagiomedical.com/.
Adagio Medical Holdings, Inc. (ADGM) operates in the Healthcare sector (Medical Devices industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-10 | $-0.30 | $-0.38 | +21.1% | $0 | — | — | EODHD |
| Q1 FY2026 | 2026-05-11 | $-0.31 | $-0.29 | -6.9% | $0 | — | — | EODHD |
| Q4 FY2025 | 2026-03-26 | $-0.16 | $-0.31 | +48.4% | $0 | — | — | EODHD |
| Q3 FY2025 | 2025-11-11 | $-0.66 | $0.00 | — | $0 | — | — | EODHD |
| Q2 FY2025 | 2025-08-13 | $-0.35 | — | — | $0 | — | — | EODHD |
| Q1 FY2025 | 2025-05-14 | $-0.51 | — | — | $-143.0K | — | — | EODHD |
| Q4 FY2024 | 2025-03-26 | $-3.75 | — | — | — | — | — | EODHD |
| Q3 FY2024 | 2024-09-29 | $-0.32 | — | — | $185.0K | — | — | EODHD |
| Q2 FY2024 | 2024-06-29 | $-6.44 | — | — | $254.0K | — | — | EODHD |
| Q1 FY2024 | 2024-03-30 | $-0.03 | — | — | $26.0K | — | — | EODHD |
| Q4 FY2023 | 2023-12-30 | $-0.28 | — | — | $78.0K | — | — | EODHD |
| Q3 FY2023 | 2023-09-29 | $-0.06 | — | — | $41.0K | — | — | EODHD |
| Q2 FY2023 | 2023-06-29 | $0.05 | — | — | $121.0K | — | — | EODHD |
| Q1 FY2023 | 2023-04-05 | $0.05 | — | — | $60.0K | — | — | EODHD |
| Q4 FY2022 | 2022-12-30 | $-0.09 | — | — | $0 | — | — | EODHD |
| Q3 FY2022 | 2022-11-06 | $0.17 | — | — | — | — | — | EODHD |
| Q2 FY2022 | 2022-08-07 | $-0.01 | — | — | — | — | — | EODHD |
| Q1 FY2022 | 2022-05-12 | $-0.01 | — | — | — | — | — | EODHD |
| Q4 FY2021 | 2022-03-30 | $-0.06 | — | — | — | — | — | EODHD |
| Q3 FY2021 | 2021-11-11 | $-0.27 | — | — | — | — | — | EODHD |
Source: EODHD. ADGM reported actuals as published; sparse fields render as —.